why choose us

First received: July 18, 2024

Clinical Trial: Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects Without Diabetes Mellitus

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Overweight and Obesity

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-controlled, Parallel-group Multicenter Trial to Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects Without Diabetes Mellitus

Brief Summary: The study is designed to evaluate the preliminary efficacy, safety, population PK profile, and immunogenicity of CPX101 in subjects with obesity or overweight with weight related comorbidities but without diabetes mellitus.

Read more